Abstract
Long noncoding RNAs (lncRNAs) have emerged as new regulatory molecules implicated in diverse biological processes, including therapeutic resistance. However, the mechanisms underlying lncRNA-mediated temozolomide (TMZ) resistance in glioblastoma (GBM) remain largely unknown. To illustrate the role of lncRNA in TMZ resistance, we induce TMZ-resistant GBM cells, perform a lncRNA microarray of the parental and TMZ-resistant cells, and find an unreported lncRNA in GBM, lnc-TALC (temozolomide-associated lncRNA in glioblastoma recurrence), correlated with TMZ resistance via competitively binding miR-20b-3p to facilitate c-Met expression. A phosphorylated AKT/FOXO3 axis regulated lnc-TALC expression in TMZ-resistant GBM cells. Furthermore, lnc-TALC increased MGMT expression by mediating the acetylation of H3K9, H3K27 and H3K36 in MGMT promoter regions through the c-Met/Stat3/p300 axis. In clinical patients, lnc-TALC is required for TMZ resistance and GBM recurrence. Our results reveal that lnc-TALC in GBM could serve as a therapeutic target to overcome TMZ resistance, enhancing the clinical benefits of TMZ chemotherapy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Animals
-
Antineoplastic Agents, Alkylating / pharmacology*
-
Antineoplastic Agents, Alkylating / therapeutic use
-
Brain Neoplasms / drug therapy*
-
Brain Neoplasms / genetics
-
Brain Neoplasms / mortality
-
Brain Neoplasms / pathology
-
Cell Line, Tumor
-
DNA Modification Methylases / metabolism
-
DNA Repair Enzymes / metabolism
-
Drug Resistance, Neoplasm / genetics*
-
Female
-
Gene Expression Profiling / methods
-
Glioblastoma / drug therapy*
-
Glioblastoma / genetics
-
Glioblastoma / mortality
-
Glioblastoma / pathology
-
Humans
-
Male
-
Mice, Inbred BALB C
-
Mice, Nude
-
MicroRNAs / metabolism*
-
Middle Aged
-
O(6)-Methylguanine-DNA Methyltransferase / metabolism*
-
Oligonucleotide Array Sequence Analysis / methods
-
Proto-Oncogene Proteins c-met / genetics
-
Proto-Oncogene Proteins c-met / metabolism
-
RNA, Long Noncoding / metabolism*
-
Survival Analysis
-
Temozolomide / pharmacology*
-
Temozolomide / therapeutic use
-
Tumor Suppressor Proteins / metabolism
-
Xenograft Model Antitumor Assays
Substances
-
Antineoplastic Agents, Alkylating
-
MIRN20a microRNA, human
-
MicroRNAs
-
RNA, Long Noncoding
-
Tumor Suppressor Proteins
-
DNA Modification Methylases
-
MGMT protein, human
-
O(6)-Methylguanine-DNA Methyltransferase
-
MET protein, human
-
Proto-Oncogene Proteins c-met
-
DNA Repair Enzymes
-
Temozolomide